One strategy to suppress ccRCC aggressiveness is directed at inhibition of HIF-2α and the associated molecular pathways leading to cell proliferation, angiogenesis, and metastasis. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.